Article Details
Retrieved on: 2025-03-29 13:17:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Finally, Catalina Capital Group LLC purchased a new stake in shares of Connect Biopharma during the 4th quarter worth $66,000. 58.72% of the stock is ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here